TD ASSET MANAGEMENT INC - CARBYLAN THERAPEUTICS INC ownership

CARBYLAN THERAPEUTICS INC's ticker is CBYL and the CUSIP is 141384107. A total of 21 filers reported holding CARBYLAN THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TD ASSET MANAGEMENT INC ownership history of CARBYLAN THERAPEUTICS INC
ValueSharesWeighting
Q2 2016$49,000
+2.1%
74,7000.0%0.00%
Q1 2016$48,000
-82.2%
74,7000.0%0.00%
-100.0%
Q4 2015$270,000
+1.1%
74,7000.0%0.00%0.0%
Q3 2015$267,000
-48.7%
74,700
+2.8%
0.00%0.0%
Q2 2015$520,00072,7000.00%
Other shareholders
CARBYLAN THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Broadfin Capital, LLC 1,178,941$4,209,0000.23%
SPHERA FUNDS MANAGEMENT LTD. 400,000$1,428,0000.18%
PURA VIDA INVESTMENTS, LLC 80,000$286,0000.16%
MENTA CAPITAL LLC 32,229$115,0000.02%
WEDBUSH SECURITIES INC 22,300$80,0000.02%
Omega Advisors Inc. 98,200$351,0000.01%
VANGUARD GROUP INC 5,091,482$170,165,0000.01%
Alyeska Investment Group, L.P. 109,241$390,0000.01%
PUTNAM INVESTMENTS LLC 635,468$2,269,0000.01%
Pentwater Capital Management LP 114,255$408,0000.00%
View complete list of CARBYLAN THERAPEUTICS INC shareholders